Search

Your search keyword '"Park, Hae-Sim"' showing total 372 results

Search Constraints

Start Over You searched for: Author "Park, Hae-Sim" Remove constraint Author: "Park, Hae-Sim" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
372 results on '"Park, Hae-Sim"'

Search Results

1. Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma

2. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts

12. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

23. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

26. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

28. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

29. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

30. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

31. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy

32. Update on latex allergy: New insights into an old problem

37. Toward personalization of asthma treatment according to trigger factors

38. COVID-19, asthma, and biological therapies: What we need to know

40. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

45. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

47. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

48. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis

Catalog

Books, media, physical & digital resources